Mesquita, DinisCarmo, PedroCabanelas, NunoSantos, NunoMartins, VítorSanfins, VictorCosta, Helena CristinaFontes, José PauloFonseca, PauloParreira, Leonor2021-10-152021-10-152021-03-15Revista Portuguesa de Cardiologia 40 (2021) 573---5800870-2551http://hdl.handle.net/10400.26/37692Introduction and objectives: In December 2019, SARS-CoV-2, was discovered as the agent of COVID-19 disease. Cardiac arrhythmias have been reported as frequent but their incidence is unknown. The aim of this research was to assess the real incidence of cardiac arrhythmias among COVID-19 patients admitted to Portuguese hospitals and to understand the underlying prognostic implications. Methods: The Portuguese Association of Arrhythmology, Pacing and Electrophysiology (APAPE) conducted a survey in Portuguese hospitals to assess the occurrence of arrhythmias in COVID-19 patients, their clinical characteristics, the use of experimental therapies and the impact on QT interval.engArrythmias cardiacasCOVID-19Portuguese Experimental TherapyQT prolongationAPAPESARS-COV-2PortugalPortuguese Hospitalsjournal article10.1016/j.repc.2020.11.007